{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:07:16Z","timestamp":1759226836366},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2004,8,1]]},"DOI":"10.1038\/sj.gt.3302292","type":"journal-article","created":{"date-parts":[[2004,8,4]],"date-time":"2004-08-04T07:15:01Z","timestamp":1091603701000},"page":"1296-1300","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control"],"prefix":"10.1038","volume":"11","author":[{"given":"L M","family":"Work","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"Nicklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P N","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A H","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,8,4]]},"reference":[{"key":"BF3302292_CR1","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1128\/JVI.75.7.3335-3342.2001","volume":"75","author":"MJE Havenga","year":"2001","unstructured":"Havenga MJE et al. Improved adenovirus vectors for infection of cardiovascular tissues. J Virol 2001; 75: 3335\u20133342.","journal-title":"J Virol"},{"key":"BF3302292_CR2","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1128\/JVI.76.9.4612-4620.2002","volume":"76","author":"M Havenga","year":"2002","unstructured":"Havenga M et al. Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. Virology 2002; 76: 4612\u20134620.","journal-title":"Virology"},{"key":"BF3302292_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1006\/mthe.2000.0205","volume":"2","author":"PN Reynolds","year":"2000","unstructured":"Reynolds PN et al. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol Ther 2000; 2: 562\u2013578.","journal-title":"Mol Ther"},{"key":"BF3302292_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/6185","volume":"17","author":"JS Bartlett","year":"1999","unstructured":"Bartlett JS, Kleinschmidt J, Boucher RC, Samulski RJ . Targeted adeno-associated virus vector transduction of non-permissive cells mediated by a bi-specific F(ab'gamma)(2) antibody. Nat Biotech 1999; 17: 181\u2013186.","journal-title":"Nat Biotech"},{"key":"BF3302292_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1566523023347797","volume":"2","author":"S Nicklin","year":"2002","unstructured":"Nicklin S, Baker A . Tropism-modified adenovirus and adeno-associated viral vectors for gene therapy. Curr Gene Ther 2002; 2: 273\u2013293.","journal-title":"Curr Gene Ther"},{"key":"BF3302292_CR6","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","volume":"72","author":"I Dmitriev","year":"1998","unstructured":"Dmitriev I et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 1998; 72: 9706\u20139713.","journal-title":"J Virol"},{"key":"BF3302292_CR7","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/sj.gt.3300941","volume":"6","author":"PN Reynolds","year":"1999","unstructured":"Reynolds PN, Dmitriev I, Curiel DT . Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector. Gene Therapy 1999; 6: 1336\u20131339.","journal-title":"Gene Therapy"},{"key":"BF3302292_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1525-0016(03)00042-X","volume":"7","author":"W Shi","year":"2003","unstructured":"Shi W, Bartlett JS . RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism. Mol Ther 2003; 7: 515\u2013525.","journal-title":"Mol Ther"},{"key":"BF3302292_CR9","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1083\/jcb.130.5.1189","volume":"130","author":"R Pasqualini","year":"1995","unstructured":"Pasqualini R, Koivunen E, Ruoslahti E . A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol 1995; 130: 1189\u20131196.","journal-title":"J Cell Biol"},{"key":"BF3302292_CR10","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320\u20131323.","journal-title":"Science"},{"key":"BF3302292_CR11","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","volume":"94","author":"RP Tomko","year":"1997","unstructured":"Tomko RP, Xu R, Philipson L . HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997; 94: 3352\u20133356.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302292_CR12","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","volume":"72","author":"C Summerford","year":"1998","unstructured":"Summerford C, Samulski RJ . Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438\u20131445.","journal-title":"J Virol"},{"key":"BF3302292_CR13","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1096\/fj.00-0145com","volume":"14","author":"MO Hiltunen","year":"2000","unstructured":"Hiltunen MO et al. Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods. FASEB J 2000; 14: 2230\u20132236.","journal-title":"FASEB J"},{"key":"BF3302292_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S1091-255X(02)00437-7","volume":"7","author":"P Nagi","year":"2003","unstructured":"Nagi P et al. Development of a therapuetic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement. J Gastrointest Surg 2003; 7: 364\u2013371.","journal-title":"J Gastrointest Surg"},{"key":"BF3302292_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/01.HYP.38.1.65","volume":"38","author":"SA Nicklin","year":"2001","unstructured":"Nicklin SA et al. Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium. Hypertension 2001; 38: 65\u201370.","journal-title":"Hypertension"},{"key":"BF3302292_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nbt0901-838","volume":"19","author":"P Reynolds","year":"2001","unstructured":"Reynolds P et al. Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat Biotechnol 2001; 19: 833\u2013842.","journal-title":"Nat Biotechnol"},{"key":"BF3302292_CR17","first-page":"1271","volume":"62","author":"G Bauerschmitz","year":"2002","unstructured":"Bauerschmitz G et al. The flt-1 promoter for transcriptional targeting in teratocarcinoma. Cancer Res 2002; 62: 1271\u20131274.","journal-title":"Cancer Res"},{"key":"BF3302292_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2003.07.003","volume":"201","author":"SA Nicklin","year":"2003","unstructured":"Nicklin SA et al. Transductional and transcriptional targeting of cancer cells using genetically-engineered viral vectors. Cancer Lett 2003; 201: 165\u2013173.","journal-title":"Cancer Lett"},{"key":"BF3302292_CR19","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1161\/01.HYP.33.6.1353","volume":"33","author":"S Kerr","year":"1999","unstructured":"Kerr S et al. Superoxide anion production is increased in a model of genetic hypertension: The role of endothelial nitric oxide synthase and superoxide dismutase isoforms. Hypertension 1999; 33: 1353\u20131358.","journal-title":"Hypertension"},{"key":"BF3302292_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ng0897-364","volume":"16","author":"B Jeffs","year":"1997","unstructured":"Jeffs B et al. Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet 1997; 16: 364\u2013367.","journal-title":"Nat Genet"},{"key":"BF3302292_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-4615-5385-4_3","volume":"432","author":"A Dominiczak","year":"1997","unstructured":"Dominiczak A et al. Left ventricular hypertophy and arterial blood pressure in experimental models of hypertension. Adv Exp Med Biol 1997; 432: 23\u201333.","journal-title":"Adv Exp Med Biol"},{"key":"BF3302292_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.gt.3301633","volume":"9","author":"JP Fennell","year":"2002","unstructured":"Fennell JP et al. Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Therapy 2002; 9: 110\u2013117.","journal-title":"Gene Therapy"},{"key":"BF3302292_CR23","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1161\/01.CIR.91.11.2793","volume":"91","author":"T Asahara","year":"1995","unstructured":"Asahara T et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995; 91: 2793\u20132801.","journal-title":"Circulation"},{"key":"BF3302292_CR24","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/01.ATV.20.6.1452","volume":"20","author":"S Wen","year":"2000","unstructured":"Wen S et al. Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wall. Arterioscl Thromb Vasc Biol 2000; 20: 1452\u20131458.","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"BF3302292_CR25","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1161\/01.CIR.100.22.2267","volume":"100","author":"HD Intengan","year":"1999","unstructured":"Intengan HD, Thibault G, Li J-S, Schiffrin EL . Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: Effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999; 100: 2267\u20132275.","journal-title":"Circulation"},{"key":"BF3302292_CR26","volume-title":"Vascular Disease: Molecular Biology and Gene Transfer Protocols (Methods in Molecular Medicine)","author":"SA Nicklin","year":"1999","unstructured":"Nicklin SA, Baker AH . Simple methods for preparing recombinant adenoviruses for high efficiency transduction of vascular cells. In: Baker AH (ed) Vascular Disease: Molecular Biology and Gene Transfer Protocols (Methods in Molecular Medicine). Humana Press: New York, 1999."},{"key":"BF3302292_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1006\/mthe.2001.0489","volume":"4","author":"SA Nicklin","year":"2001","unstructured":"Nicklin SA et al. Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. Mol Ther 2001; 4: 534\u2013542.","journal-title":"Mol Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302292","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:35:09Z","timestamp":1648614909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,1]]},"references-count":27,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2004,8,1]]}},"alternative-id":["BF3302292"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302292","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,1]]},"assertion":[{"value":"13 October 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}